Immunogenicity and risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection after Coronavirus Disease 2019 (COVID-19) vaccination in patients with cancer: a systematic review and meta-analysis

Author:

Becerril-Gaitan Andrea,Vaca-Cartagena Bryan F.,Ferrigno Ana S.,Mesa-Chavez FernandaORCID,Barrientos-Gutiérrez Tonatiuh,Tagliamento MarcoORCID,Lambertini MatteoORCID,Villarreal-Garza Cynthia

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference73 articles.

1. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China;Liang;Lancet Oncol,2020

2. Immune responses to COVID-19 vaccines in patients with cancer: promising results and a note of caution;Griffiths;Cancer Cell,2021

3. Mortality in adult patients with solid or hematological malignancies and SARS-CoV-2 infection with a specific focus on lung and breast cancers: a systematic review and meta-analysis;Tagliamento;Crit Rev Oncol Hematol,2021

4. WHO Director-General’s opening remarks at the media briefing on COVID-19 - 3 March 2020,2021

5. Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial;Marconi;Lancet Respir Med,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3